FDA Reissues Notice Announcing Increased OTC Monograph Facility Fees

Published date02 April 2021
Subject MatterFDA,Fees,Pharmaceutical Industry,CARES Act,Manufacturers,Over The Counter Drugs (OTC),FD&C Act,Coronavirus/COVID-19
AuthorL. Christine Lawson
Law FirmWomble Bond Dickinson

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT